Extracellular ATP regulates FoxO family of transcription factors and cell cycle progression through PI3K/Akt in MCF-7 cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 10, 2013, Pages 4456-4469

  Scodelaro Bilbao, Paola ^a   Boland, Ricardo ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

Cell cycle; Extracellular ATP; FoxO transcription factors; MCF 7 cells; PI3K Akt

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENOSINE TRIPHOSPHATE; BORTEZOMIB; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO;

ARTICLE; CELL COUNT; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL NUCLEUS; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; EXTRACELLULAR SPACE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL CYCLE; EXTRACELLULAR ATP; FOXO TRANSCRIPTION FACTORS; MCF-7 CELLS; PI3K/AKT;

ADENOSINE TRIPHOSPHATE; BLOTTING, WESTERN; CELL CYCLE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MCF-7 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING;

EID: 84879464950     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.05.034     Document Type: Article

References (49)

1. T. Deli, and L. Csernoch Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors Pathol. Oncol. Res. 14 2008 219 231
2. P. Scodelaro Bilbao, S. Katz, and R. Boland Role of extracellular ATP in cell fate determination Immun. Endoc. Metab. Agents Med. Chem. 11 2011 48 58
3. P. Scodelaro Bilbao, R. Boland, A. Russo de Boland, and G. Santillán ATP modulation of mitogen activated protein kinases and intracellular Ca2 + in breast cancer (MCF-7) cells Arch. Biochem. Biophys. 466 2007 15 23 (Pubitemid 47405079)
4. P. Scodelaro Bilbao, R. Boland, and G. Santillán ATP modulates transcription factors through P2Y2 and P2Y4 receptors via PKC/MAPKs and PKC/Src pathways in MCF-7 cells Arch. Biochem. Biophys. 494 2010 7 14
5. P. Scodelaro Bilbao, G. Santillán, and R. Boland ATP stimulates the proliferation of MCF-7 cells through the PI3K/Akt signaling pathway Arch. Biochem. Biophys. 499 2010 40 48
6. K. Maiese, Z.Z. Chong, Y.C. Shang, and J. Hou Clever cancer strategies with FoxO transcription factors Cell Cycle 7 2008 3829 3839
7. C. Weidinger, K. Krause, A. Klagge, S. Karger, and D. Fuhrer Forkhead box-O transcription factor: critical conductors of cancer's fate Endocr. Relat. Cancer 15 2008 917 929
8. P.K. Vogt, H. Jiang, and M. Aoki Triple layer control: phosphorylation, acetylation and ubiquitination of FoxO proteins Cell Cycle 4 2005 908 913 (Pubitemid 41359756)
9. L.P. van der Heide, M.F. Hoekman, and M.P. Smidt The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation Biochem. J. 380 2004 297 309 (Pubitemid 38788101)
10. J.Y. Yang, and M.C. Hung A new fork for clinical application: targeting forkhead transcription factors in cancer Clin. Cancer Res. 15 2009 752 757
11. C.J. Sherr G1 phase progression: cycling on cue Cell 79 1994 551 555 (Pubitemid 24363798)
12. T. Hirama, and H.P. Koeffler Role of the cyclin-dependent kinase inhibitors in the development of cancer Blood 86 1995 841 854
13. A. Besson, S.F. Dowdy, and J.M. Roberts CDK inhibitors: cell cycle regulators and beyond Dev. Cell 14 2008 159 169 (Pubitemid 351189186)
14. D. Erlinge Extracellular ATP: a growth factor for vascular smooth muscle cells Gen. Pharmacol. 31 1998 1 8 (Pubitemid 28239746)
15. M. Bradford A rapid and sensitive method for quantification of microgram quantities of proteins utilizing the principle of protein binding Anal. Biochem. 72 1976 248 254
16. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
17. K. Módis, D. Gero, N. Nagy, P. Szoleczky, Z.D. Tóth, and C. Szabó Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis Br. J. Pharmacol. 158 2009 1565 1578
18. N. Nakamura, S. Ramaswamy, F. Vazquez, S. Signoretti, M. Loda, and W.R. Sellers Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN Mol. Cell. Biol. 20 2000 8969 8982 (Pubitemid 32245927)
19. C. Bouchard, J. Marquardt, A. Brás, R.H. Medema, and M. Eilers Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins EMBO J. 23 2004 2830 2840 (Pubitemid 39013555)
20. J. Seoane, H.V. Le, L. Shen, S.A. Anderson, and J. Massagué Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation Cell 117 2004 211 223 (Pubitemid 38496241)
21. Z. Jagani, K. Song, J.L. Kutok, M.R. Dewar, A. Melet, T. Santos, A. Grassian, S. Ghaffari, C. Wu, H. Yeckes-Rodin, R. Ren, K. Miller, and R. Khosravi-Far Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors Cancer Res. 69 2009 6546 6555
22. F. Di Virgilio Purines, purinergic receptors, and cancer Cancer Res. 72 2012 5441 5447
23. A. Erol Deciphering the intricate regulatory mechanisms for the cellular choice between cell repair, apoptosis or senescence in response to damaging signals Cell. Signal. 23 2011 1076 1081
24. K. Maiese, J. Hou, Z.Z. Chong, and Y.C. Shang A fork in the path: developing therapeutic inroads with FoxO proteins Oxid. Med. Cell Longev. 2 2009 119 129
25. E.L. Greer, and A. Brunet FoxO transcription factors at the interface between longevity and tumor suppression Oncogene 24 2005 7410 7425 (Pubitemid 41637981)
26. Z. Fu, and D.J. Tindall FoxOs, cancer and regulation of apoptosis Oncogene 27 2008 2312 2319 (Pubitemid 351501782)
27. V. Modur, R. Nagarajan, B.M. Evers, and J. Milbrandt FoxO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer J. Biol. Chem. 277 2002 47928 47937 (Pubitemid 36159321)
28. R.L. Lynch, B.W. Konicek, A.M. McNulty, K.R. Hanna, J.E. Lewis, and B.L. Neubauer The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FoxO3a expression and reduced p27KIP1 promoter transactivation Mol. Cancer Res. 3 2005 163 169 (Pubitemid 40524899)
29. Y. Zou, W.B. Tsai, C.J. Cheng, C. Hsu, Y.M. Chung, and P.C. Li Forkhead box transcription factor FoxO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis Breast Cancer Res. 10 2008 21
30. S. Thevananther, H. Sun, D. Li, V. Arjunan, S.S. Awad, S. Wyllie, T.L. Zimmerman, J.A. Goss, and S.J. Karpen Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes Hepatology 39 2004 393 402 (Pubitemid 38222180)
31. M.J. Yoon, H.J. Lee, J.H. Kim, and D.K. Kim Extracellular ATP induces apoptotic signaling in human monocyte leukemic cells, HL-60 and F-36P Arch. Pharm. Res. 29 2006 1032 1041
32. M.X. Wang, and L.M. Ren Growth inhibitory effect and apoptosis induced by extracellular ATP and adenosine on human gastric carcinoma cells: involvement of intracellular uptake of adenosine Acta Pharmacol. Sin. 27 2006 1085 1092
33. T. Kawase, K. Okuda, and H. Yoshie Extracellular ATP and ATPgammaS suppress the proliferation of human periodontal ligament cells by different mechanisms J. Periodontol. 78 2007 748 756
34. A.A. Bernardo, F.E. Pinto-Silva, P.M. Persechini, R. Coutinho-Silva, J.R. Meyer-Fernandes, A.L. de Souza, and V.M. Rumjanek Effect of extracellular ATP on the human leukaemic cell line K562 and its multidrug counterpart Mol. Cell. Biochem. 289 2006 111 124 (Pubitemid 44322481)
35. T.G. Kalemi, K.T. Papazisis, A.F. Lambropoulos, S. Voyatzi, A. Kotsis, and A.H. Kortsaris Expression of the HER family mRNA in breast cancer tissue and association with cell cycle inhibitors p21(waf1) and p27(kip1) Anticancer Res. 27 2007 913 920 (Pubitemid 46586999)
36. A. Devault, J.C. Cavadore, D. Fesquet, J.C. Labbé, T. Lorca, A. Picard, U. Strausfeld, and M. Dorée Concerted roles of cyclin A, cdc25 + mitotic inducer, and type 2A phosphatase in activating the cyclin B/cdc2 protein kinase at the G2/M phase transition Cold Spring Harb. Symp. Quant. Biol. 56 1991 503 513
37. S. van den Heuvel, and E. Harlow Distinct roles for cyclin-dependent kinases in cell cycle control Science 262 1993 2050 2054 (Pubitemid 24041887)
38. C.J. Sherr, and J.M. Roberts Living with or without cyclins and cyclin-dependent kinases Genes Dev. 18 2004 2699 2711 (Pubitemid 39507762)
39. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
40. Q. Zhang, K. Sakamoto, C. Liu, A.A. Triplett, W.C. Lin, H. Rui, and K.U. Wagner Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression Cancer Res. 71 2011 7513 7524
41. J.J. Michels, F. Duigou, J. Marnay, M. Henry-Amar, T. Delozier, Y. Denoux, and J. Chasle Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance Cancer 97 2003 1376 1386 (Pubitemid 36297766)
42. R.V. Lloyd, L.A. Erickson, L. Jin, E. Kulig, X. Qian, J.C. Cheville, and B.W. Scheithauer p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers Am. J. Pathol. 154 1999 313 323 (Pubitemid 29094081)
43. W. Li, A. Sanki, R.Z. Karim, J.F. Thompson, C. Soon Lee, and L. Zhuang The role of cell cycle regulatory proteins in the pathogenesis of melanoma Pathology 38 2006 287 301 (Pubitemid 44266625)
44. J. Liang, and J.M. Slingerland Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression Cell Cycle 2 2003 339 345
45. A. Cappellini, G. Tabellini, M. Zweyer, R. Bortul, P.L. Tazzari, A.M. Billi, F. Falà, L. Cocco, and A.M. Martelli The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression Leukemia 17 2003 2157 2167 (Pubitemid 37428381)
46. G. Viglietto, M.L. Motti, P. Bruni, R.M. Melillo, A. D'Alessio, and D. Califano Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer Nat. Med. 8 2002 1136 1144 (Pubitemid 35175969)
47. J. Kiang, J. Zubovitz, T. Petrocelli, R. Kotchekov, M.K. Connor, and K. Han PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Nat. Med. 8 2002 1153 1160 (Pubitemid 35175971)
48. E. Tokunaga, E. Oki, A. Egashira, N. Sadanaga, N. Morita, Y. Kakeji, and Y. Maehara Curr. Cancer Drug Targets 8 2008 27 36
49. M. Schmidt, S. Fernandez de Mattos, A. van der Horst, R. Klompmaker, G.J. Kops, E.W. Lam, B.M. Burgering, and R.H. Medema Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D Mol. Cell. Biol. 22 2002 7842 7852 (Pubitemid 35217295)